1. Home
  2. CCTG vs CTXR Comparison

CCTG vs CTXR Comparison

Compare CCTG & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCTG
  • CTXR
  • Stock Information
  • Founded
  • CCTG 1993
  • CTXR 2007
  • Country
  • CCTG Hong Kong
  • CTXR United States
  • Employees
  • CCTG N/A
  • CTXR N/A
  • Industry
  • CCTG
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCTG
  • CTXR Health Care
  • Exchange
  • CCTG Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • CCTG 14.9M
  • CTXR 14.6M
  • IPO Year
  • CCTG 2024
  • CTXR N/A
  • Fundamental
  • Price
  • CCTG $1.10
  • CTXR $1.58
  • Analyst Decision
  • CCTG
  • CTXR Strong Buy
  • Analyst Count
  • CCTG 0
  • CTXR 3
  • Target Price
  • CCTG N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • CCTG 5.9K
  • CTXR 6.8M
  • Earning Date
  • CCTG 08-23-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • CCTG N/A
  • CTXR N/A
  • EPS Growth
  • CCTG N/A
  • CTXR N/A
  • EPS
  • CCTG N/A
  • CTXR N/A
  • Revenue
  • CCTG $16,463,490.00
  • CTXR N/A
  • Revenue This Year
  • CCTG N/A
  • CTXR N/A
  • Revenue Next Year
  • CCTG N/A
  • CTXR N/A
  • P/E Ratio
  • CCTG N/A
  • CTXR N/A
  • Revenue Growth
  • CCTG 3.27
  • CTXR N/A
  • 52 Week Low
  • CCTG $0.99
  • CTXR $0.65
  • 52 Week High
  • CCTG $3.17
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • CCTG 45.98
  • CTXR 68.44
  • Support Level
  • CCTG $1.05
  • CTXR $0.76
  • Resistance Level
  • CCTG $1.12
  • CTXR $1.45
  • Average True Range (ATR)
  • CCTG 0.04
  • CTXR 0.31
  • MACD
  • CCTG 0.01
  • CTXR 0.06
  • Stochastic Oscillator
  • CCTG 70.00
  • CTXR 47.63

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: